Botulinum toxin in the treatment of zygomatic fractures.
Kayikçioğlu
Aycan
A
Hacettepe University Medical Faculty, Department of Plastic and Reconstructive Surgery, Ankara, Turkey. akayikci@hacettepe.edu.tr
Erk
Yücel
Y
Mavili
Emin
E
Vargel
Ibrahim
I
Ozgür
Figen
F
D000328:Adult; D000368:Aged; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D005593:Fracture Fixation, Internal; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008406:Masseter Muscle; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D011300:Preoperative Care; D011859:Radiography; D015051:Zygomatic Fractures / Q000000981:diagnostic imaging / Q000601:surgery*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A